Concepedia

Extended-release Formulation Evaluation

Extended-Release Formulation Evaluation is a systematic pharmaceutical assessment method that characterizes the in vitro and in vivo performance of extended-release drug products to determine their rate and extent of drug release over time, ensuring therapeutic equivalence and bioavailability relative to a reference formulation.

326

Publications

13.4K

Citations

1.6K

Authors

614

Institutions

Publications per year

2017–2026

47

Parents

Publications

326

A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Joseph Biederman, Raun D. Melmed, Anil Patel et al. · PEDIATRICS · 2007 · 313 citations

, , +17

Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study

Stephen R. Marder, Michelle Kramer, Lisa Ford et al. · Biological Psychiatry · 2007 · 234 citations

, , +10

Emergence of Adverse Events Following Discontinuation of Treatment With Extended-Release Venlafaxine

Maurizio Fava, Rosemarie Mulroy, Jonathan E. Alpert et al. · American Journal of Psychiatry · 1997 · 198 citations

, , +14

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of SLI381 (Adderall XR) in Children With Attention-Deficit/Hyperactivity Disorder

Joseph Biederman, Frank A. López, Samuel W. Boellner et al. · PEDIATRICS · 2002 · 180 citations

, , +17

Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers

Atul Kuksal, Ashok K. Tiwary, N. K. Jain et al. · AAPS PharmSciTech · 2006 · 170 citations · Full text

, , +16

1–5 of 326

Authors

1.6K

  1. PM
    Patrick Marroum

    AbbVie (United States), United States

    7 publications · 401 citations

    7

    h-index

  2. SD
    Sandeep Dutta

    Abbott Fund, United States

    6 publications · 238 citations

    6

    h-index

  3. JB
    Joseph Biederman

    Massachusetts General Hospital, United States

    5 publications · 652 citations

    5

    h-index

  4. LR
    Lynn R. Webster

    PRA Health Sciences, United States

    4 publications · 92 citations

    4

    h-index

  5. TW
    Torsten Wagner

    FH Aachen, Germany

    4 publications · 204 citations

    4

    h-index

1–5 of 1.6K

Institutions

614

  1. Massachusetts General Hospital

    Boston, United States

    10 h-index

    19 publications

    1.2K citations

  2. University of Maryland, Baltimore

    Baltimore, United States

    9 h-index

    18 publications

    793 citations

  3. Pfizer (United States)

    New York, United States

    8 h-index

    33 publications

    1.4K citations

  4. Abbott Fund

    Chicago, United States

    8 h-index

    26 publications

    1.3K citations

  5. Center for Drug Evaluation and Research

    Silver Spring, United States

    7 h-index

    23 publications

    755 citations

  6. United States Food and Drug Administration

    Silver Spring, United States

    7 h-index

    18 publications

    791 citations

  7. Bristol-Myers Squibb (United States)

    New York, United States

    6 h-index

    20 publications

    1.4K citations

  8. Takeda (United States)

    Deerfield, United States

    6 h-index

    15 publications

    835 citations

1–8 of 614

Venues

  1. International Journal of Pharmaceutics

    13 publications · 407 citations

    13

    h-index

  2. Clinical Therapeutics

    15 publications · 361 citations

    11

    h-index

  3. The Journal of Clinical Pharmacology

    12 publications · 442 citations

    11

    h-index

  4. PubMed

    Repository · 10 publications · 307 citations

    10

    h-index

  5. European Journal of Pharmaceutics and Biopharmaceutics

    EJPB · 9 publications · 585 citations

    9

    h-index

1–5